To further validate whether SOX9 expression correlates with that of BCL2, tumour tissues from six DLBCL cases were subjected to immunohistochemistry to determine the BCL2 and SOX9 expression levels. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.